Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 13 results:
Author Title Type [ Year(Asc)]
Filters: Author is Vasilakis-Scaramozza, C.  [Clear All Filters]
2020
R. Persson, Vasilakis-Scaramozza, C., Hagberg, K. W., Sponholtz, T., Williams, T., Myles, P., and Jick, S. S., “CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities”, Pharmacoepidemiol Drug Saf, 2020.
S. S. Jick, Hagberg, K. W., Persson, R., Vasilakis-Scaramozza, C., Williams, T., Crellin, E., and Myles, P., “Quality and completeness of diagnoses recorded in the new CPRD Aurum Database: evaluation of pulmonary embolism”, Pharmacoepidemiol Drug Saf, 2020.
2013
C. Vasilakis-Scaramozza, Aschengrau, A., Cabral, H., and Jick, S. S., “Antidepressant use during early pregnancy and the risk of congenital anomalies”, Pharmacotherapy, vol. 33, pp. 693-700, 2013.
C. Vasilakis-Scaramozza, Aschengrau, A., Cabral, H. J., and Jick, S. S., “Antihypertensive drugs and the risk of congenital anomalies”, Pharmacotherapy, vol. 33, pp. 476-82, 2013.
C. Vasilakis-Scaramozza, Aschengrau, A., Cabral, H. J., and Jick, S. S., “Asthma drugs and the risk of congenital anomalies”, Pharmacotherapy, vol. 33, pp. 363-8, 2013.
2003
S. S. Jick, Kaye, J. A., Vasilakis-Scaramozza, C., Rodriguez, L. A. Garcia, Ruigomez, A., Meier, C. R., Schlienger, R. G., Black, C., and Jick, H., “Validity of the general practice research database”, Pharmacotherapy, vol. 23, pp. 686-9, 2003.
2002
C. J. Kornegay, Vasilakis-Scaramozza, C., and Jick, H., “Incident diabetes associated with antipsychotic use in the United Kingdom general practice research database”, J Clin Psychiatry, vol. 63, pp. 758-62, 2002.
2001
H. Jick, Vasilakis-Scaramozza, C., and Jick, S. S., “Live attenuated polio vaccine and the risk of intussusception”, Br J Clin Pharmacol, vol. 52, pp. 451-3, 2001.
S. S. Jick, Vasilakis-Scaramozza, C., and Maier, W. C., “The risk of cataract among users of inhaled steroids”, Epidemiology, vol. 12, pp. 229-34, 2001.
C. Vasilakis-Scaramozza and Jick, H., “Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives”, Lancet, vol. 358, pp. 1427-9, 2001.
2000
C. Gasse, Derby, L., Vasilakis-Scaramozza, C., and Jick, H., “Incidence of first-time idiopathic seizures in users of tramadol”, Pharmacotherapy, vol. 20, pp. 629-34, 2000.
S. S. Jick, Kremers, H. M., and Vasilakis-Scaramozza, C., “Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide”, Arch Dermatol, vol. 136, pp. 1231-6, 2000.
H. Jick, Kaye, J. A., Vasilakis-Scaramozza, C., and Jick, S. S., “Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis”, Bmj, vol. 321, pp. 1190-5, 2000.
[Page last reviewed 6 April 2021]